One study examined how inhibiting miR-15b-5p will suppress cell death in Parkinson’s disease (PD) by focusing on the Akt3-mediated GSK-3/catenin signaling pathway (Zhu J. et al., 2021). Here, AKT3 is linked to Parkinson disease.